Close
Back to LEGN Stock Lookup

(LEGN) – PRNewswire

Apr 18, 2024 09:00 AM Bluecrux & Pharmaceutical Innovator Forge Path Toward QC & Supply Chain Integration: "Revolutionizing Lab Operations for Enhanced Efficiency"
Mar 25, 2024 04:05 PM Poseida Therapeutics Appoints Syed Rizvi, M.D., as Chief Medical Officer
Mar 12, 2024 08:15 AM GenScript Biotech Announces 2023 Annual Results with a Five-Year CAGR stands at 30%
Jan 12, 2024 10:28 AM San Francisco Witnesses the Voice of GCT Titans GenScript Biotech Global Forum Outlines the Future of the Industry
Jan 4, 2024 04:37 AM GenScript, GenScript ProBio, and Legend Biotech Will Attend the 42nd JPM Healthcare Conference, Advancing Innovation and Development in the Healthcare Sector
Jan 4, 2024 03:55 AM GenScript Biotech Global Forum 2024 to Commence, Infusing New Vitality into the GCT Industry
Dec 24, 2023 09:15 PM FDA Keynote Speaker in the Spotlight, CAR-T Industry Leaders Gather for Discussion-Join the 2024 GenScript Biotech Global Forum for a New Journey in Cell and Gene Therapy
Dec 14, 2023 07:34 AM Titans Gather, Future Embarks: The GenScript Biotech Global Forum coinciding with the 2024 J.P. Morgan Healthcare Conference in San Francisco to Convene 20+ KOLs, Exploring Disruptive Transformations
Dec 7, 2023 06:25 AM CRISPR Continuous to Innovate! Exploring the Future of Cell & Gene Therapy, Industry Leaders Converge at the 2024 GenScript Biotech Global Forum
Jun 27, 2023 10:47 PM Riding the Waves of Foreign Trade: The Rise of China's Brands in 2023
Jun 26, 2023 08:30 AM ICHNOS SCIENCES WELCOMES LIDA PACAUD, M.D., AS NEW CHIEF MEDICAL OFFICER
May 29, 2023 08:03 AM CELL WORLD - Aiming at Internationalization, Starting from Regulation - The 1st Global Cell Therapy Summit and Hillgene Biopharma Anniversary Celebration Successfully Held
Mar 30, 2023 08:40 PM Genscript Biotech Reports 2022 Annual Results*
Dec 6, 2022 01:49 PM Jackie Veivia-Panter Joins BioCentriq as Chief Quality and Compliance Officer
Aug 31, 2022 08:45 AM The International Myeloma Foundation (IMF) Highlights #kNOwMyeloma Campaign for Blood Cancer Awareness Month 2022
Jul 26, 2022 06:00 AM GenScript to Host 2nd Annual Gene & Cell Engineering Virtual Summit
May 17, 2022 09:00 AM PM360 Announces Winners of The Eighth Annual ELITE Awards
Mar 20, 2022 10:47 AM Genscript Biotech Reports 2021 Annual Results
Feb 28, 2022 08:48 PM U.S. FDA Approves CARVYKTI™ (ciltacabtagene autoleucel), Janssen's First Cell Therapy, a BCMA-Directed CAR-T Immunotherapy for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma
Dec 7, 2021 08:33 AM China's Largest Commercial GMP Plasmid Manufacturing Facility is Put into Operation, GenScript ProBio Expanding Manufacturing Capacity Again
Oct 11, 2021 07:00 AM Cellares Appoints John Tomtishen as Vice President of Operations
Aug 24, 2021 09:38 AM GenScript Biotech Reports First Half 2021 Results
Mar 29, 2021 11:38 AM GenScript Biotech Reports Full Year 2020 Financial Results and Business Results
Dec 21, 2020 07:00 AM Janssen Initiates Rolling Submission of a Biologics License Application to U.S. FDA for BCMA CAR-T Therapy Ciltacabtagene Autoleucel (cilta-cel) for the Treatment of Relapsed and/or Refractory Multipl
Dec 5, 2020 03:00 PM Early, Deep, Durable Responses of Ciltacabtagene Autoleucel (cilta-cel) Observed in Phase 1b/2 CARTITUDE-1 Study Show Potential of BCMA CAR-T in Treatment of Heavily Pretreated Patients with Multiple
Aug 30, 2020 11:24 PM GenScript Reports 2020 Interim Results and Provides Business Update

Back to LEGN Stock Lookup